PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Research and Development Unit, Parc Sanitari Sant Joan de Déu, Barcelona, Spain.\', \'Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.\', \'IQVIA, London, UK.\', \'German Diabetes Center, Institute for Biometrics and Epidemiology, Duesseldorf, Germany.\', \'Epidemiology, IQVIA, Frankfurt, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/dom.14293
?:hasPublicationType
?:journal
  • Diabetes, obesity & metabolism
is ?:pmid of
?:pmid
?:pmid
  • 33319440
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Change in glucose-lowering medication regimens in individuals with type 2 diabetes mellitus during the COVID-19 pandemic in Germany.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all